Material and Methods: Patients with cataract and SO endotamponate (Group I) and senile cataract (Group II) were included in this study. Patients had PE-IOL implantation operation. Two groups were compared for corrected visual acuity (CVA), intraocular pressure (IOP) measurements and complications at preoperative, postoperative 3th and 6th month controls.

Results: In Group I 15 eyes of the 15 patients [M/F=9/6, age=63.53±4.74 years] and in Group II 15 eyes of the 15 patients [M/F=7/8, age=62.86±4.74 years] were included in this study. The follow-up after PE-IOL implantation operation was 7.13±0.99 months (6-9 months) in Group I and 7.03±1.18 months (6-9 months) in Group II. With Group I and Group II turn, CVA measurements were 2.03±0.74 LogMar (1.0-3.0 LogMar) and 0.58±0.15 LogMar (0.43-1LogMar) before PE-IOL implantation operation, 1.61±0.84 LogMar (0.5-3.0 LogMar) and 0.02±0.04 LogMar (0-1 LogMar) 3 months after operation, 1.5±0.70 LogMar (0.2-3.0 LogMar) and 0.02±0.03 LogMar (0-1 LogMar) 6 months after operation. In both groups there were significant improvement for CVA at postoperative 3th and 6th months controls with respect to preoperative CVA. There was not a significant change in IOP at postoperative 3th and 6th months controls with respect to preoperative IOP. Posterior capsule opacification was observed significantly more in Group I (40%) than Group II (13%) patients.

Conclusion: PE-IOL implantation operation is safe and effective in patients with in patients with cataract and silicone oil endotamponade. Keywords : Intraocular lens, phacoemulsification, silicone oil